Endothelial Cell Activation and Total Pulmonary Resistance in PAH
NCT06035861
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Artery Hypertension
Interventions
DRUG:
XBD173
Sponsor
Imperial College London